Sale of AgeX subsidiary will help support development of BioTime’s core programs Balance owed for remaining portion of transaction totals $21.6 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results